Launching Biosimilars in Emerging Markets

In the lead up to the forthcoming “Biosimilars Commercialisation Summit” happening in May 2019, Pharma IQ had the opportunity to interview industry experts:

Jose Carlos Ferreyra, President at Mexican Pharmaceutical Institute
Fabiola Santillan, Country Manager at TTY Biopharm
Pankaj Chaudhari, Manager - Global Regulatory Affairs (Biosimilars) at IQVIA

They shared their thoughts on the key factors to take into account when launching in the South Asian and Latin American regions.

Download the full interviews to get insights on how to win in these markets.

Please note: That all fields marked with an asterisk (*) are required.

First Name *

Last Name *

Job Title *

Company Name *

Email Address *

Telephone *

Mobile Telephone

Country *

Where did you hear about us?

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.